Skip to main content
. 2023 Mar 16;11:1152207. doi: 10.3389/fbioe.2023.1152207

FIGURE 6.

FIGURE 6

BM-MSCsec increased GAG content in treated hNPCs. (A) GAG/DNA ratio in hNPCs after MSC secretome treatment demonstrated a significant increase in the group treated with BM-MSCsec. (B) Following IL-1β pretreatment, both BM-MSCsec and ADSCsec demonstrated to rescue GAG/DNA levels compared to the group treated with IL-1β only. Data are expressed as GAG/DNA ratio percent variation between the control and experimental groups. *p < 0.05, **p < 0.01.